Expression of CD34 and other haematopoietic antigens on neuroblastoma cells: Consequences for autologous bone marrow and peripheral blood stem cell transplantation

Journal of Neuroimmunology

Volumn 78, Issue 1-2, 1997, Pages 117-126

  Voigt, Astrid ^a   Häfer, Ralf ^a   Gruhn, Bernd ^a   Zintl, Felix ^a  

^a Oncol Immunol Childrens Hosp F   (Germany)

Author keywords

Antigens; CD34; Hematopoietic stem cell transplantation; Neoplasm circulating cells; Neuroblastoma

Indexed keywords

CD34 ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; AUTOGRAFT; BONE MARROW TRANSPLANTATION; CELL VIABILITY; CROSS REACTION; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NEUROBLASTOMA CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS; ANTIGENS, CD34; BLOOD CELLS; BONE MARROW TRANSPLANTATION; CROSS REACTIONS; EPITOPES; HEMATOPOIESIS; HUMANS; MICE; MICE, SCID; NEUROBLASTOMA; STEM CELL TRANSPLANTATION; TUMOR CELLS, CULTURED;

EID: 0342894829     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00088-X     Document Type: Article

References (33)

1. + marrow cells in patients with breast cancer or neuroblastoma. Blood. 77:1991;1717-1722.
2. x and dependent and independent recognition pathways. Blood. 82:1993;182-191.
3. Civin, C.I., 1995. Purification and expansion of haemopoietic stem cells. In: Schlossmann, S.F. et al. (Eds.), Leucocyte Typing V. White Cell Differentiation Antigens, vol. 1. Oxford, pp. 869-871.
4. Civin C.I., Trischman T., Kadan N.S., Davis J.E., Noga S.J., Cohen K.J., Duffy B., Groenewegen J., Wiley J., Law P., Hardwick A., Oldham F., Gee A. Highly purified CD34-positive cells reconstitute hematopoiesis. J. Clin. Oncol. 14:1996;2224-2233.
5. Di-Caro A., Bostrom B., Moss T.J., Neglia J., Ramsay N.K., Smith J., Lasky L.C. Autologous peripheral blood cell transplantation in the treatment of advanced neuroblastoma. Am. J. Pediatr. Hematol. Oncol. 16:1994;200-206.
6. Dominici C., Deb G., Angioni A., Landolfo A., Parisi F., Helson L. Peripheral blood stem cells in children with solid tumors. Part II. Immunocytologic detection of tumor cells in bone marrow and peripheral blood stem cell harvests. Anticancer Res. 13:1993;2573-2575.
7. Ebener U., Wehner S., Cinatl J., Gussetis E.S., Kornhuber B. Expression of markers shared between human hematopoietic cells and neuroblastoma cells. Anticancer Res. 10:1990;887-890.
8. Fackler M.J., Civin C., Stratford M.W. Up regulation of surface CD34 disassociated with proteinkinase C-mediated hyperphosphorylation of CD34. J. Biol. Chem. 267:1992;7540-7546.
9. Garofalo A., Chirivi R.G.S., Scanziani E., Mayo J.G., Vecchi A., Glavazzi R. Comparative study on the metastatic behaviour of human tumors in nude, beige/nude/Xid and severe combined immunodeficient mice. Invasion Metastasis. 13:1993;82-91.
10. Gaudernack, G. and Egeland, T., 1995. Epitope mapping of 33 CD34 mAb, including the Fifth Workshop panel. In: Schlossmann, S.F. et al. (Eds.), Leucocyte Typing V. White Cell Differentiation Antigens, vol. 1. Oxford, pp. 861-864.
11. Holyoake T.L., Alcorn M.J. CD34-positive haemopoietic cells: Biology and clinical applications. Blood Rev. 8:1994;113-124.
12. Kanold J., Berger M., Rapatel C., De-Lumley L., Lutz P., Plantaz D., Vannier J.P., Bergeron C., Mechinaud F., Favrot M. CD34+ cell immunoselection from G-CSF-alone-primed peripheral blood in children with low body mass. Br. J. Haematol. 91:1995;431-433.
13. Kemshead J.T., Bicknell D., Greaves M.F. A monoclonal antibody detecting an antigen shared by neural and granulocytic cells. Pediatr. Res. 15:1981;1282-1286.
14. + human hematopoietic progenitor cells. Ann. Hematol. 70:1995;281-296.
15. Komada Y., Azuma E., Kamiya H., Sakurai M. Phenotypic profile of human neuroblastoma cell lines: Association with morphological characteristics. Br. J. Cancer. 54:1986;711-715.
16. Krause D.S., Fackler M.J., Civin C.I., Stratford M.W. CD34: Structure, biology, and clinical utility. Blood. 87:1996;1-13.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
18. Leung W., Chen A.R., Klann R.C., Moss T.J., Davis J.E., Noga S.J., Kent H.W., Conway J.M., Cohen K.J., Friedman A.D., Small D., Schwartz C.L., Civin C.I. Tumor cells frequently detected in marrow and mobilized blood hematopoietic grafts in neuroblastoma and primitive neuroectodermal tumor: Purging by immunomagnetic CD34+ cell selection. Part I of II. Blood. 88 (Suppl. 1):1996;482. abstract.
19. Mapara M.Y., Körner I.J., Hildebrandt M., Bargou R., Krahl D., Reichardt P., Dörken B. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: Comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood. 89:1997;337-344.
20. McGarry R.C., Pinto A., Hammersley-Straw D.R.H., Trevenen C.L. Expression of markers shared between human natural killer cells and neuroblastoma lines. Cancer Immunol. Immunother. 27:1988;47-52.
21. Moss T.J., Sanders D.G., Lasky L.C., Bostrom B. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood. 76:1990;1879-1883.
22. Moss T.J., Cairo M., Santana V.M., Weinthal J., Hurvitz C., Bostrom B. Clonogenicity of circulating neuroblastoma cells: Implications regarding peripheral blood stem cell transplantation. Blood. 83:1994;3085-3089.
23. Piazentini M., Fesus L., Melino G. Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells. FEBS Lett. 320:1993;150-154.
24. Ponzoni M., Guarnaccia F., Corrias M.V., Cornaglia-Ferraris P. Uncoordinate induction and differential regulation of HLA class-I and class-II expression by gamma-interferon in differentiating human neuroblastoma cells. Int. J. Cancer. 55:1993;817-823.
25. Ross R.A., Spengler B.A., Biedler J.L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 7:1983;741-747.
26. Sugimoto T., Tatsumi E., Kemshead J.T., Helson L., Green A.A., Minowada J. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies. J. Natl. Cancer Inst. 73:1984;51-57.
27. Sugimoto T., Horii Y., Hino T., Kemshead J.T., Kuroda H., Sawada T., Morioka H., Imanishi J., Inoko H. Differential susceptibility of HLA class-II antigens induced by gamma-interferon in human neuroblastoma cell lines. Cancer Res. 49:1989;1824-1828.
28. Tonini G.P. Neuroblastoma: The result of multistep transformation? Stem Cells. 11:1993;276-282.
29. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. 76:1979;4350-4354.
30. Verbeek W., Pies A., Humpe A., Grove D., Troff C., Kunze E., Hiddemann W., Wormann B. Mobilization of CD34-positive tumor cells in a patient with testicular mixed germ cell tumor. Br. J. Haematol. 90:1995;947-950.
31. Voigt A., Häfer R., Zintl F. Monoclonal antibodies against neuroblastoma. Production and preliminary characterization of their specificity. J. Neuroimmunol. 43:1993;125-130.
32. Weiss S.H., Nickoloff B.J. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am. J. Surg. Pathol. 17:1993;1039-1045.
33. + myeloma cells. Br. J. Haematol. 93:1996;613-622.